New

AI v2.0 Beta Launched. Experience the future of pharmaceutical care.

Try Now
Drug info language
Switches all medical info on this page (labels, indications, leaflet) without changing the rest of the interface.
OTCTranslated

OLICLINOMEL N7-1000 E

10%/40%/20%/Emulsion for Intravenous Perfusion/ACIDES AMINES/GLUCOSE/LIPIDES
BAXTER
ManufacturerVerified lab

BAXTER

Public retail price
N/ADZD

Identification

Active ingredient (INN)
ACIDES AMINES/GLUCOSE/LIPIDES
Internal code
14 K 323
Country of Origin
Belgium
Pharmaceutical form
Emulsion for Intravenous Perfusion
Prescription List
OTC
Packaging
poche de 3 compartiments de 1000ml(400ml/400ml/200ml)
OLICLINOMEL N7-1000 E
Clinical View

DAWA Clinical Workbench v2.0

Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.

Associated Conditions

Lactation General anesthesia Angor de Prinzmetal

Recent history of myocardial infarction Stenosing periphery arterial disease Asthma First degree atrial cell Chronic obstructive Bronchopneumopathy Cardiomyopathy restrictive Congenital Cardiology Diabetes Child under 15 years of age Female likely to be pregnant Pregnancy Hyperthyroidism Heart failure Coronary heart failure Hepatic impairment Renal impairment Surgical intervention Newborn exposed in utero to the medicine Phoechromocytoma Psoriasis Psoriasis, history Sports Subject to strict fasting Treatment of desensitization in progress Cardiac valvulopathy.

Mechanism of Action

Mechanism of action

Bisoprolol is a beta-blocker with a high affinity for beta-1 receptors, without intrinsic sympathomimetic activity, or membrane stabilizing effect.

It has only a low affinity for beta-2 receptors in smooth bronchi and vessel muscles and beta-2 receptors involved in metabolic regulation.

As a result, bisoprolol generally does not alter airway resistance and has no metabolic effects related to action on beta-2 receptors.

The beta-1 selectivity of bisoprolol extends beyond therapeutic doses.

Adverse Effects

  • Liver enzymes (increase) (Rare)
  • Hypoglycaemia (Rare)
  • Hypertriglyceridaemia (Rare)
  • Antinuclear body (increase) (Rare)
  • ASAT (increase)
  • ALT (increase)
  • Psoriasiform eruption (Very rare)
  • Alopecia (Very rare)
  • Psoriasis (Very rare)
  • Psoriasis (aggravation) (Very rare)
  • Rash
  • Pruritus Coldness at the ends (Common)
  • Numbness of the extremities (Common)
  • Asthenia (Common)
  • Fatigue (Common)
  • Hepatitis (Rare)
  • Hypersensitivity (Rare)
  • Lupic syndrome (Exceptional)
  • Angioedema Lacrymal hyposecretion (Rare)
  • Conjunctivitis (Very rare)
  • Vertigo (Common)
  • Allergic Rhinitis (Rare)
  • Hearing disorder (Rare)
  • Depression (Uncommon)
  • Sleep disorder (Uncommon)
  • Nightmare (Rare)
  • Hallucination (Rare)
  • Bradycardia (Very common)
  • Raynaud's syndrome (Common)
  • Atrialculoventric block (Uncommon)
  • Orthostatic hypotension (Uncommon)
  • Hypotension (Common)
  • Heart failure (aggravation) (Common)
  • Intermittent clauding (aggravation) (Common)
  • Syncope (Rare)
  • Congestive puff Digestive disorder (Common)
  • Vomiting Constipation
  • Nausea Abdominal pain Diarrhoea Cramp (Uncommon)
  • Muscle weakness (Uncommon)
  • Arthropathy (Uncommon)
  • Headache (Common)
  • Bronchospasm (Uncommon)
  • Erection disorder (Rare).

Alternatives